Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cesium is a chemical element and alkali metal that is not a canonical biological target but is highly significant in the fields of toxicology, oncology, and electrophysiology. In its ionic form (Cs+), cesium acts as a potent blocker of various potassium channels, most notably the delayed rectifier potassium current (IKr) and hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which can lead to severe cardiotoxicity and life-threatening arrhythmias such as Torsades de Pointes [10, 11]. While stable cesium chloride has been erroneously promoted in alternative medicine as a high pH cancer therapy, this practice is scientifically unsupported and associated with significant safety risks, including cardiac arrest and severe electrolyte imbalances [13, 14]. Conversely, radioactive isotopes such as Cesium-137 and Cesium-131 are established therapeutic agents in clinical oncology, utilized as radiation sources in brachytherapy to deliver targeted treatment to localized tumors in the prostate or cervix [2, 7]. The primary pharmacological intervention for cesium exposure or internal contamination is the administration of Prussian Blue (ferric hexacyanoferrate), which acts as a sequestering agent to facilitate the fecal excretion of the metal and reduce its biological half-life [8, 16].
Prussian Blue (ferric hexacyanoferrate) acts as an ion-exchange resin that traps cesium ions within its crystal lattice in the gastrointestinal tract, preventing absorption and interrupting enterohepatic circulation to enhance fecal elimination [16].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cesium (Cs).